Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentativeapproval by the United States Food & Drug Administration (U.S. FDA) for Dapagliflozin and Saxagliptin Tablets, 10 mg/5 mg, the generic version of Qtern®1Tablets, 10 mg/5 mg, of AstraZeneca AB.
In a major step to make India self-reliant in COVID-19 testing, Mylab Discovery Solutions, a Pune based molecular diagnostics has collaborated with Kiran Mazumdar Shaw’s Syngene, a leading global contract research organization, to cater to India’s demand for RT-PCR COVID-19 testing kits.
Despite the COVID-19 crisis, the Indian Pharmaceutical market registered a surprising growth of 8.9% in Mar’20 with some evidence of panic buying in Chronic Medicines as reported by AIOCD AWACS.
Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (US FDA).
In September 2019, The USFDA has observed that, some ranitidine medicines contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. SMS Pharma is one of the manufacturer of Ranitidine HCl Active Pharmaceuticals Ingredient (API).
Pharma major Lupin Limited (Lupin) announced a contribution of INR 21 crores for relief efforts directed towards mitigating the COVID-19 crisis. Lupin’s Global Giving Program comprises of three separate contributions made by its employees, the Company and the promoter family.
BioNTech SE and Pfizer Inc disclosed additional details of their collaboration to advance candidates from BioNTech’s mRNA vaccine program, previously announced on March 17, 2020.
The U.S. Food and Drug Administration issued an emergency use authorization for a blood purification system to treat patients 18 years of age or older with confirmed Coronavirus Disease 2019 (COVID-19) admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure.
Sun Pharmaceuticals shares are floating higher to Rs. 452.50 on BSE on Friday and expected to improve company's outlook. It was reached 52 week high at Rs. 479.90 on 10th April, 2020.
HLL has introduced rapid diagnostic kit under the brand name Make Sure for the quick detection of Corona virus. The test result will be available within 15 to 20 minutes. The test kit is being manufactured at HLL Manesar Factory, Gurgaon.
The kit is one-step novel coronavirus IgM/IgG antibody detection from the human serum, plasma and/or whole blood obtained from the patient with signs and symptoms of respiratory infection.
This device is designed to aid in the rapid differential diagnosis of COVID-19 virus infection in large population screening in our country during the current pandemic situation and this shall support in the management of control and treatment of coronavirus disease
This kit is validated and approved by the NIV, Pune and the ICMR for use in India.
The principle of 'MakeSure' COVID-19 IgM/IgG antibody test kit is based on antibody capture immunochromatographic assay for the simultaneous detection of IgM and IgG antibodies to COVID-19 virus in human serum, plasma and/or whole blood samples.
HLL is planning to manufacture two lakh kits for supplying to various government units within the next 10 days. Along with that HLL has also started manufacturing of hand sanitizers under the brand name "Medigard" at their Peroorkada Factory, Thiruvananthapuram and Kanagala Factory, Belgaum.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
